Advocacy at a Glance STEVEN GROSSMAN 5/28/21 Advocacy at a Glance STEVEN GROSSMAN 5/28/21 The President’s FY 22 Budget is being released on May 28. An analysis of the FDA request will be provided to Alliance members following our internal review. Read More Analysis and Commentary STEVEN GROSSMAN 5/21/21 Analysis and Commentary STEVEN GROSSMAN 5/21/21 Messaging for Upcoming Senate Hill Days Read More Advocacy at a Glance STEVEN GROSSMAN 5/21/21 Advocacy at a Glance STEVEN GROSSMAN 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More Advocacy at a Glance STEVEN GROSSMAN 5/16/21 Advocacy at a Glance STEVEN GROSSMAN 5/16/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Key Take-Aways from Hill Day (Part One) Read More Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Advocacy at a Glance STEVEN GROSSMAN 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More Analysis and Commentary STEVEN GROSSMAN 4/23/21 Analysis and Commentary STEVEN GROSSMAN 4/23/21 Alliance "Hill Day": April 28 and 29 Read More Advocacy at a Glance STEVEN GROSSMAN 4/16/21 Advocacy at a Glance STEVEN GROSSMAN 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More Advocacy at a Glance STEVEN GROSSMAN 3/20/20 Advocacy at a Glance STEVEN GROSSMAN 3/20/20 Alliance Completes Hill Day with Conference Calls and Much Enthusiasm on Both Sides Read More Advocacy at a Glance STEVEN GROSSMAN 3/13/20 Advocacy at a Glance STEVEN GROSSMAN 3/13/20 The Alliance’s March 18 Hill Day Is Still On; New Format to Deliver FDA Funding Message Safely Read More Analysis and Commentary STEVEN GROSSMAN 3/5/20 Analysis and Commentary STEVEN GROSSMAN 3/5/20 Additional funding for FDA; more Qs and As Read More Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Alliance Hill Day On March 18; You Don’t Have to Be an FDA Expert to Participate Read More Analysis and Commentary STEVEN GROSSMAN 2/27/20 Analysis and Commentary STEVEN GROSSMAN 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More Advocacy at a Glance STEVEN GROSSMAN 2/28/20 Advocacy at a Glance STEVEN GROSSMAN 2/28/20 Coronavirus Supplemental Likely to Be Considered Quickly Read More Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Alliance FY 21 “Ask” Set at $120 million above the FY 20 BA Appropriation Read More Analysis and Commentary STEVEN GROSSMAN 2/1/20 Analysis and Commentary STEVEN GROSSMAN 2/1/20 FDA's FY 21 Appropriation: What's Happening When? Read More Advocacy at a Glance STEVEN GROSSMAN 2/1/20 Advocacy at a Glance STEVEN GROSSMAN 2/1/20 Upcoming Hill Opportunity for Alliance Members Read More Analysis and Commentary STEVEN GROSSMAN 1/17/20 Analysis and Commentary STEVEN GROSSMAN 1/17/20 Hill Day and Other Upcoming Alliance Advocacy Initiatives Read More Advocacy at a Glance STEVEN GROSSMAN 1/10/20 Advocacy at a Glance STEVEN GROSSMAN 1/10/20 Before Focusing on FY 21 Funding: A Recap of FY 20 Read More Older Posts
Advocacy at a Glance STEVEN GROSSMAN 5/28/21 Advocacy at a Glance STEVEN GROSSMAN 5/28/21 The President’s FY 22 Budget is being released on May 28. An analysis of the FDA request will be provided to Alliance members following our internal review. Read More
Analysis and Commentary STEVEN GROSSMAN 5/21/21 Analysis and Commentary STEVEN GROSSMAN 5/21/21 Messaging for Upcoming Senate Hill Days Read More
Advocacy at a Glance STEVEN GROSSMAN 5/21/21 Advocacy at a Glance STEVEN GROSSMAN 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More
Advocacy at a Glance STEVEN GROSSMAN 5/16/21 Advocacy at a Glance STEVEN GROSSMAN 5/16/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More
Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More
Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Key Take-Aways from Hill Day (Part One) Read More
Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Advocacy at a Glance STEVEN GROSSMAN 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More
Analysis and Commentary STEVEN GROSSMAN 4/23/21 Analysis and Commentary STEVEN GROSSMAN 4/23/21 Alliance "Hill Day": April 28 and 29 Read More
Advocacy at a Glance STEVEN GROSSMAN 4/16/21 Advocacy at a Glance STEVEN GROSSMAN 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More
Advocacy at a Glance STEVEN GROSSMAN 3/20/20 Advocacy at a Glance STEVEN GROSSMAN 3/20/20 Alliance Completes Hill Day with Conference Calls and Much Enthusiasm on Both Sides Read More
Advocacy at a Glance STEVEN GROSSMAN 3/13/20 Advocacy at a Glance STEVEN GROSSMAN 3/13/20 The Alliance’s March 18 Hill Day Is Still On; New Format to Deliver FDA Funding Message Safely Read More
Analysis and Commentary STEVEN GROSSMAN 3/5/20 Analysis and Commentary STEVEN GROSSMAN 3/5/20 Additional funding for FDA; more Qs and As Read More
Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Alliance Hill Day On March 18; You Don’t Have to Be an FDA Expert to Participate Read More
Analysis and Commentary STEVEN GROSSMAN 2/27/20 Analysis and Commentary STEVEN GROSSMAN 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More
Advocacy at a Glance STEVEN GROSSMAN 2/28/20 Advocacy at a Glance STEVEN GROSSMAN 2/28/20 Coronavirus Supplemental Likely to Be Considered Quickly Read More
Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Alliance FY 21 “Ask” Set at $120 million above the FY 20 BA Appropriation Read More
Analysis and Commentary STEVEN GROSSMAN 2/1/20 Analysis and Commentary STEVEN GROSSMAN 2/1/20 FDA's FY 21 Appropriation: What's Happening When? Read More
Advocacy at a Glance STEVEN GROSSMAN 2/1/20 Advocacy at a Glance STEVEN GROSSMAN 2/1/20 Upcoming Hill Opportunity for Alliance Members Read More
Analysis and Commentary STEVEN GROSSMAN 1/17/20 Analysis and Commentary STEVEN GROSSMAN 1/17/20 Hill Day and Other Upcoming Alliance Advocacy Initiatives Read More
Advocacy at a Glance STEVEN GROSSMAN 1/10/20 Advocacy at a Glance STEVEN GROSSMAN 1/10/20 Before Focusing on FY 21 Funding: A Recap of FY 20 Read More
